T. Rowe Price Associates’s MBX Biosciences, Inc. Common Stock MBX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$15.4M	Buy	1,346,910 +245,994	+22%	+$2.81M	﹤0.01%	1016
2025 Q1	$8.13M	Sell	1,100,916 -60,611	-5%	-$447K	﹤0.01%	1149
2024 Q4	$21.4M	Sell	1,161,527 -31,411	-3%	-$579K	﹤0.01%	978
2024 Q3	$31M	Buy	+1,192,938	New	+$31M	﹤0.01%	881